Coronary Artery Bypass Graft Market Outlook for (2023 to 2033)

The coronary artery bypass graft market is estimated to be valued at US$ 17,612.1 million in 2023. The coronary artery bypass graft industry is likely to cross a valuation of US$ 22,765.9 million by 2033. The coronary artery bypass graft market is currently experiencing a sluggish CAGR of 2.6%

  • In developed regions, the market has reached a level of maturity where most eligible patients have undergone coronary artery bypass graft procedures. This saturation limits the potential for rapid expansion.
  • Stringent regulatory requirements and lengthy approval processes for medical devices and surgical procedures affect the introduction of new technologies and innovations. Manufacturers often face substantial challenges in meeting these compliance standards.
  • Economic fluctuations and healthcare budget constraints in some regions directly impact the market's growth. Reduced healthcare spending can lead to delays in planned coronary artery bypass graft surgeries, hindering market expansion.

Despite the current sluggish growth, the coronary artery bypass graft market has the potential for a resurgence in the forecast period.

Demand Analysis in the Coronary Artery Bypass Graft

  • The persistent rise in cardiovascular diseases, driven by factors like sedentary lifestyles and poor dietary habits, is expected to fuel the demand for coronary artery bypass graft procedures. An aging population further amplifies this demand.
  • Ongoing advancements in surgical techniques, graft materials, and medical devices are poised to rejuvenate the market. These innovations enhance the efficacy and safety of coronary artery bypass graft surgeries, making them more appealing to patients and healthcare providers.
  • Developing regions with improving healthcare infrastructure and growing cardiovascular health awareness represent untapped growth opportunities. As more individuals gain access to healthcare services, the demand for coronary artery bypass graft procedures is likely to surge.
  • The trend towards personalized medicine is gaining momentum, and it's expected to reshape the market. Tailoring treatment plans and graft selection to individual patient needs can significantly improve outcomes, attracting a broader patient base.
Attributes Details
Coronary Artery Bypass Graft Market Value for 2023 US$ 17,612.1 million
Coronary Artery Bypass Graft Market Value for 2033 US$ 22,765.9 million
Coronary Artery Bypass Graft Market Forecast CAGR for 2023 to 2033 2.6%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Historical Performance and Future Growth of the Coronary Artery Bypass Graft Market

Historical CAGR 6.1%
Forecast CAGR 2.6%

The section presents an intriguing blend of historical performance and future growth prospects. With a historical CAGR of 6.1%, the coronary artery bypass graft market has demonstrated commendable growth. This upward trajectory was attributed to the increasing prevalence of cardiovascular diseases, continuous advancements in surgical techniques, graft materials, and medical devices, as well as heightened awareness among patients regarding the importance of cardiovascular health.

The coronary artery bypass graft market is anticipated to rise at a CAGR of 2.6% through 2033. This projected lower growth rate is primarily a result of market saturation in developed regions and economic factors that can influence healthcare spending. Nevertheless, the market remains a critical component of cardiovascular care, and growth opportunities persist through technological innovations and addressing the rising burden of cardiovascular diseases, particularly in emerging markets.

Short-term Analysis of Coronary Artery Bypass Graft Market from 2018 to 2022

2018 US$ 12,857.2 million
2022 US$ 16,599.5 million

From 2018 to 2022, the coronary artery bypass graft market exhibited notable growth, with the market value increasing from US$ 12,857.2 million to US$ 16,599.5 million. This surge can be primarily attributed to an aging population, lifestyle-related cardiovascular issues, and advancements in medical technology. Patients and healthcare providers sought CABG procedures as a reliable solution to address critical heart conditions during this period.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Mid-term Analysis of Coronary Artery Bypass Graft Market from 2023 to 2028

2023 US$ 17,612.1 million
2028 US$ 20,023.75 million

In the mid-term analysis from 2023 to 2028, the CABG market is anticipated to continue its growth trend. Starting at US$ 17,612.1 million in 2023, the market is projected to reach US$ 20,023.75 million by 2028. This growth is driven by ongoing innovations in minimally invasive CABG techniques, increased healthcare infrastructure investment, and a growing emphasis on preventive cardiology. These factors together bolster the demand for coronary artery bypass graft procedures and associated medical products and services.

Long-term Analysis of Coronary Artery Bypass Graft Market from 2028 to 2033

2028 US$ 20,023.75 million
2033 US$ 22,765.9 million

Looking further ahead to the long-term analysis from 2028 to 2033, the coronary artery bypass graft market is expected to reach US$ 22,765.9 million. While the CAGR may appear moderate at 2.6%, it signifies a maturing market as coronary artery bypass graft procedures become more standardized. However, this also presents opportunities for market players to focus on enhancing post-operative care and ensuring the long-term success of coronary artery bypass graft patients.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Key Trends Influencing the Coronary Artery Bypass Graft Market

Trend Details
Minimally Invasive CABG Manufacturers are developing advanced surgical instruments, while healthcare providers offer these techniques to patients for quicker recovery.
Robotic CABG Medical device companies have created robotic systems for precision, aiding surgeons in coronary artery bypass graft procedures to enhance surgical outcomes.
Hybrid CABG Hospitals are adopting hybrid approaches, combining open and minimally invasive techniques providing tailored solutions to patients with complex coronary issues.
Off-pump CABG Suppliers have introduced specialized equipment for off-pump surgeries, allowing surgeons to perform CABG, minimizing complications.
Arterial Grafts Medical device manufacturers have produced high-quality arterial grafts, improved patient outcomes, and reduced the need for saphenous vein grafts.
Bioresorbable Grafts Investors are funding research in bioresorbable graft technology, which could revolutionize CABG by eliminating the long-term need for permanent grafts.

Category-wise Insights

The section includes a segmentation analysis of the coronary artery bypass graft industry. It highlights that the dominant technology type in 2023 is Off-pump, capturing a significant market share of 55.5%. Also, the section reveals that hospitals are the top-end users of coronary artery bypass graft procedures, holding a substantial market share of 63.2% in 2023. These insights provide a detailed understanding of the prevalent technologies and primary end users in the market.

Dominance of Off-pump Technology in Coronary Artery Bypass Graft Procedures

Attributes Details
Top Technology Type Off-pump
Market Share in 2023 55.5%

Off-pump technology leads the coronary artery bypass graft (CABG) market with an impressive 55.5% market share in 2023.

  • Off-pump CABG's minimally invasive nature appeals to patients and surgeons alike, contributing to its popularity. Manufacturers can capitalize on the growing demand for off-pump technology, given its significant market share, by investing in research and development and expanding product portfolios.
  • The technology's ability to lower post-operative complications drives its adoption.
  • Patients experience shorter hospital stays and quicker recoveries with off-pump coronary artery bypass grafts. This factor attracts manufacturers in the industry to capitalize on this opportunity.
  • Continuous innovations by industry players are expanding the adoption of off-pump technology in various cardiac procedures.

Hospitals Become the Key End Users Fueling Coronary Artery Bypass Graft Sales Growth

Attributes Details
Top End User Type Hospitals
Market Share in 2023 63.2%

Hospitals play a pivotal role in the coronary artery bypass graft market, holding a substantial market share of 63.2% in 2023.

  • Hospitals offer comprehensive cardiac care facilities, making them a default choice for coronary artery bypass graft procedures. Manufacturers can collaborate with hospitals to develop tailored coronary artery bypass graft solutions that meet the specific needs of clinical settings.
  • Well-equipped hospitals provide the necessary infrastructure for coronary artery bypass graft surgeries, including dedicated operating rooms and skilled medical staff. Investors might consider supporting hospital-focused initiatives to enhance cardiac care infrastructure and technological capabilities
  • Hospitals often receive patient referrals from primary care physicians and other healthcare providers, boosting their coronary artery bypass graft caseload.
  • Hospitals can respond promptly to acute cardiac cases, underscoring their significance in propelling the sales of coronary artery bypass grafts.

Country-wise Insights

This section analyzes the coronary artery bypass graft market by discussing shares held by different countries in 2023. Notably, the United States dominates the market with a substantial share of 54.1%, signifying its significant contribution to the industry. Germany, the United Kingdom, China, and India each hold smaller but noteworthy market shares, reflecting diverse regional interests and opportunities within the coronary artery bypass graft industry. These insights offer valuable information for stakeholders seeking to navigate the coronary artery bypass graft industry and plan expansion strategies.

The United States Leading the CABG Market with Advanced Healthcare Infrastructure

The United States leads the coronary artery bypass graft (CABG) market in 2023.

  • The United States boasts advanced healthcare infrastructure, fostering the adoption of coronary artery bypass graft procedures.
  • A significant prevalence of cardiovascular diseases in the USA drives the demand for coronary artery bypass graft surgeries.
  • Continuous advancements in medical technology enhance coronary artery bypass graft procedures' safety and efficacy.
  • An aging population contributes to increased cases of heart-related issues, creating a steady coronary artery bypass graft demand.
  • Widespread health insurance coverage ensures accessibility to coronary artery bypass graft surgeries for a broad demographic.

Germany's Niche Coronary Artery Bypass Graft Market Thriving on Medical Tourism

Germany coronary artery bypass graft market reflects a niche but evolving sales outlook. While the market is relatively small, some factors are anticipated to contribute to its growth.

  • Germany's focus on healthcare innovation drives the adoption of advanced CABG procedures.
  • Investment in research and development initiatives supports cutting-edge cardiac surgery techniques.
  • Germany attracts medical tourists seeking high-quality cardiac treatments, bolstering coronary artery bypass graft demand.
  • An aging demographic contributes to an increased prevalence of cardiac issues and coronary artery bypass graft procedures.
  • Stringent quality standards in the German healthcare system ensure top-notch coronary artery bypass graft services.
Countries CAGR from 2023 to 2033
United Kingdom 1.6%
China 3.4%
India 3.9%
Japan 6.1%

Nationalized Healthcare System Drives the Adoption of Coronary Artery Bypass Graft in the United Kingdom

In 2023, the United Kingdom coronary artery bypass graft market is projected to witness 1.6% CAGR through 2033, signaling sluggish growth. However, the future holds space for growth.

  • The NHS (National Health Service) encourages patient access to coronary artery bypass graft surgeries.
  • The United Kingdom's medical device sector supports the development and adoption of CABG-related technologies.
  • Collaborations between universities and healthcare institutions drive coronary artery bypass graft research and expertise.
  • Patient awareness initiatives promote cardiac health, leading to increased coronary artery bypass graft adoption.
  • The private healthcare sector supplements NHS services, offering coronary artery bypass graft procedures.

Healthy Lifestyle Campaigns and Traditional Medicine Integration Drives Coronary Artery Bypass Graft Sales in China

With a 3.4% CAGR from 2023 to 2033, China's coronary artery bypass graft market shows significant potential for expansion.

  • Government initiatives promote healthy lifestyles and heart health, reducing cardiovascular risks.
  • Expanding healthcare infrastructure in rural areas enables coronary artery bypass graft accessibility beyond urban centers.
  • Traditional Chinese medicine practices complement coronary artery bypass graft procedures for holistic patient care.
  • China adopts telemedicine and healthcare technology, improving coronary artery bypass graft patient outcomes.
  • Collaborations with international healthcare institutions enhance coronary artery bypass graft expertise and techniques.

Telemedicine and a Patient-Centric Approach Drives Coronary Artery Bypass Graft Adoption in India

In 2023, India is rising at a 3.9% CAGR in the global coronary artery bypass graft market, which indicates the sluggish momentum. However, the future outlook holds immense potential for coronary artery bypass graft manufacturers.

  • Telemedicine and digital health platforms enable remote consultations and post-coronary artery bypass graft care.
  • Coronary artery bypass graft adoption extends to smaller cities and towns, reducing healthcare disparities.
  • Ayurvedic and traditional medicine practices merge with coronary artery bypass graft for a holistic approach.
  • India offers cost-effective coronary artery bypass graft procedures, attracting medical tourists globally.
  • Indian hospitals emphasize personalized patient care to enhance coronary artery bypass graft experiences.

Regenerative Medicine Integration to Propel Coronary Artery Bypass Graft Sales in Japan

With a 6.1% CAGR from 2023 to 2033, Japan maintains steady growth in a mature coronary artery bypass graft market.

  • Japan excels in robot-assisted coronary artery bypass graft procedures, improving precision and outcomes.
  • The country leverages its experience managing an aging population to refine CABG protocols.
  • Japan explores regenerative medicine applications in CABG for cardiac tissue repair.
  • National health campaigns promote heart health and preventive measures.
  • Japan's research institutions focus on cardiac innovations, attracting coronary artery bypass graft experts.

Companies Shaping the Future Outlook of the Coronary Artery Bypass Graft Industry

The coronary artery bypass graft industry is marked by the presence of established players, including medical device manufacturers, healthcare institutions, and research organizations. Prominent players such as Medtronic, Abbott Laboratories, and Terumo Corporation hold significant market shares, offering a wide range of CABG-related products and services.

Innovation is a cornerstone of competition in the coronary artery bypass graft industry. Leading companies continually invest in research and development to introduce cutting-edge technologies. These innovations include minimally invasive coronary artery bypass graft procedures, robotic-assisted surgeries, and advanced graft materials like bioresorbable and drug-eluting grafts. Manufacturers focus on enhancing the safety, efficacy, and patient outcomes associated with CABG interventions.

Collaborations between coronary artery bypass graft centers, medical device manufacturers, and healthcare providers have become increasingly prevalent. These partnerships aim to streamline patient care, ensure access to the latest coronary artery bypass graft technologies, and establish a cohesive approach to cardiac surgery. Such collaborations foster knowledge exchange and strengthen the overall ecosystem.

Leading players engage in clinical trials and research endeavors to validate the safety and efficacy of new coronary artery bypass graft techniques, devices, and materials. These studies contribute to evidence-based practices and support regulatory approvals, boosting consumer confidence and market adoption.

Recent Developments in the Coronary Artery Bypass Graft Industry

  • Medtronic received FDA approval for its new HeartWare HVAD Pump System, a smaller and more efficient left ventricular assist device (LVAD) for patients with advanced heart failure.
  • Boston Scientific acquired CryoCath Technologies, a company developing innovative technologies for treating cardiac arrhythmias.
  • On June 30, 2023, Johnson & Johnson received FDA approval for its new Prevail CRT-D System, a cardiac resynchronization therapy defibrillator (CRT-D) device designed to improve heart function and reduce the risk of sudden cardiac death in patients with heart failure.
  • On May 19, 2023, Edwards Lifesciences announced a new partnership with Google Cloud to develop AI-powered solutions for managing heart disease.

Key Companies in the Market

  • Medtronic
  • TERUMO CORPORATION
  • Guidant Group
  • MAQUET Holding B.V. & Co. K.G.
  • Vitalitec International, Inc.
  • Novadaq Technologies Inc.
  • KARL STORZ GmbH & Co. K.G.
  • Edwards Lifesciences
  • Genesee Biomedical Inc.
  • Sorin Group

Key Segments

By Technology:

  • Off-pump CABG
  • On-pump CABG
  • Others

By Procedure:

  • Single CABG surgery
  • Double CABG surgery
  • Triple CABG surgery
  • Quadruple CABG surgery
  • Others

By End User:

  • Hospitals
  • Cardiology Clinics
  • Research Institutes
  • Others

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • Europe
  • Middle East and Africa

Frequently Asked Questions

How Big is the Coronary Artery Bypass Grafts Market in 2023?

The market is estimated to be worth US$ 17,612.1 million in 2023.

What is the Market Potential for Coronary Artery Bypass Graft?

The coronary artery bypass graft market is projected to expand at a CAGR of 2.6% between 2023 and 2033.

Which End Use Segment Dominates the Coronary Artery Bypass Graft Market?

The hospital segment dominates the coronary artery bypass graft market.

What is the Coronary Artery Bypass Graft Market Growth Outlook for 2033?

The coronary artery bypass graft market is anticipated to surpass US$ 22,765.9 million by 2033.

What is Driving the Demand for Coronary Artery Bypass Graft?

Increasing prevalence of cardiovascular diseases and advancements in CABG technologies.

Who are the Top Three Coronary Artery Bypass Graft Manufacturers?

The top three manufacturers include Medtronic, Abbott Laboratories, and Terumo Corporation.

How are Sales of Off-pump CABG Performing in the Market?

Sales of off-pump CABG are driven by its minimally invasive nature and lower post-operative complications.

Table of Content
1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Technology Roadmap Analysis
    1.5. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
    3.3. Opportunity Map Analysis
    3.4. Investment Feasibility Matrix
    3.5. PESTLE and Porter’s Analysis
    3.6. Regulatory Landscape
        3.6.1. By Key Regions
        3.6.2. By Key Countries
    3.7. Regional Parent Market Outlook
4. Global Market 2018 to 2022 and Forecast, 2023 to 2033
    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Global Market 2018 to 2022 and Forecast 2023 to 2033, By Technology
    5.1. Introduction / Key Findings
    5.2. Historical Market Size Value (US$ Million) Analysis By Technology, 2018 to 2022
    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technology, 2023 to 2033
        5.3.1. Off-pump CABG
        5.3.2. On-pump CABG
        5.3.3. Others
    5.4. Y-o-Y Growth Trend Analysis By Technology, 2018 to 2022
    5.5. Absolute $ Opportunity Analysis By Technology, 2023 to 2033
6. Global Market 2018 to 2022 and Forecast 2023 to 2033, By Procedure
    6.1. Introduction / Key Findings
    6.2. Historical Market Size Value (US$ Million) Analysis By Procedure, 2018 to 2022
    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Procedure, 2023 to 2033
        6.3.1. Single CABG surgery
        6.3.2. Double CABG surgery
        6.3.3. Triple CABG surgery
        6.3.4. Quadruple CABG surgery
        6.3.5. Others
    6.4. Y-o-Y Growth Trend Analysis By Procedure, 2018 to 2022
    6.5. Absolute $ Opportunity Analysis By Procedure, 2023 to 2033
7. Global Market 2018 to 2022 and Forecast 2023 to 2033, By End User
    7.1. Introduction / Key Findings
    7.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022
    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033
        7.3.1. Hospitals
        7.3.2. Cardiology Clinics
        7.3.3. Research Institutes
        7.3.4. Others
    7.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
    7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
8. Global Market 2018 to 2022 and Forecast 2023 to 2033, By Region
    8.1. Introduction
    8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
    8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
        8.3.1. North America
        8.3.2. Latin America
        8.3.3. Western Europe
        8.3.4. Eastern Europe
        8.3.5. South Asia and Pacific
        8.3.6. East Asia
        8.3.7. Middle East and Africa
    8.4. Market Attractiveness Analysis By Region
9. North America Market 2018 to 2022 and Forecast 2023 to 2033, By Country
    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        9.2.1. By Country
            9.2.1.1. USA
            9.2.1.2. Canada
        9.2.2. By Technology
        9.2.3. By Procedure
        9.2.4. By End User
    9.3. Market Attractiveness Analysis
        9.3.1. By Country
        9.3.2. By Technology
        9.3.3. By Procedure
        9.3.4. By End User
    9.4. Key Takeaways
10. Latin America Market 2018 to 2022 and Forecast 2023 to 2033, By Country
    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        10.2.1. By Country
            10.2.1.1. Brazil
            10.2.1.2. Mexico
            10.2.1.3. Rest of Latin America
        10.2.2. By Technology
        10.2.3. By Procedure
        10.2.4. By End User
    10.3. Market Attractiveness Analysis
        10.3.1. By Country
        10.3.2. By Technology
        10.3.3. By Procedure
        10.3.4. By End User
    10.4. Key Takeaways
11. Western Europe Market 2018 to 2022 and Forecast 2023 to 2033, By Country
    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        11.2.1. By Country
            11.2.1.1. Germany
            11.2.1.2. UK
            11.2.1.3. France
            11.2.1.4. Spain
            11.2.1.5. Italy
            11.2.1.6. Rest of Western Europe
        11.2.2. By Technology
        11.2.3. By Procedure
        11.2.4. By End User
    11.3. Market Attractiveness Analysis
        11.3.1. By Country
        11.3.2. By Technology
        11.3.3. By Procedure
        11.3.4. By End User
    11.4. Key Takeaways
12. Eastern Europe Market 2018 to 2022 and Forecast 2023 to 2033, By Country
    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        12.2.1. By Country
            12.2.1.1. Poland
            12.2.1.2. Russia
            12.2.1.3. Czech Republic
            12.2.1.4. Romania
            12.2.1.5. Rest of Eastern Europe
        12.2.2. By Technology
        12.2.3. By Procedure
        12.2.4. By End User
    12.3. Market Attractiveness Analysis
        12.3.1. By Country
        12.3.2. By Technology
        12.3.3. By Procedure
        12.3.4. By End User
    12.4. Key Takeaways
13. South Asia and Pacific Market 2018 to 2022 and Forecast 2023 to 2033, By Country
    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        13.2.1. By Country
            13.2.1.1. India
            13.2.1.2. Bangladesh
            13.2.1.3. Australia
            13.2.1.4. New Zealand
            13.2.1.5. Rest of South Asia and Pacific
        13.2.2. By Technology
        13.2.3. By Procedure
        13.2.4. By End User
    13.3. Market Attractiveness Analysis
        13.3.1. By Country
        13.3.2. By Technology
        13.3.3. By Procedure
        13.3.4. By End User
    13.4. Key Takeaways
14. East Asia Market 2018 to 2022 and Forecast 2023 to 2033, By Country
    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        14.2.1. By Country
            14.2.1.1. China
            14.2.1.2. Japan
            14.2.1.3. South Korea
        14.2.2. By Technology
        14.2.3. By Procedure
        14.2.4. By End User
    14.3. Market Attractiveness Analysis
        14.3.1. By Country
        14.3.2. By Technology
        14.3.3. By Procedure
        14.3.4. By End User
    14.4. Key Takeaways
15. Middle East and Africa Market 2018 to 2022 and Forecast 2023 to 2033, By Country
    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        15.2.1. By Country
            15.2.1.1. GCC Countries
            15.2.1.2. South Africa
            15.2.1.3. Israel
            15.2.1.4. Rest of MEA
        15.2.2. By Technology
        15.2.3. By Procedure
        15.2.4. By End User
    15.3. Market Attractiveness Analysis
        15.3.1. By Country
        15.3.2. By Technology
        15.3.3. By Procedure
        15.3.4. By End User
    15.4. Key Takeaways
16. Key Countries Market
    16.1. USA
        16.1.1. Pricing Analysis
        16.1.2. Market Share Analysis, 2022
            16.1.2.1. By Technology
            16.1.2.2. By Procedure
            16.1.2.3. By End User
    16.2. Canada
        16.2.1. Pricing Analysis
        16.2.2. Market Share Analysis, 2022
            16.2.2.1. By Technology
            16.2.2.2. By Procedure
            16.2.2.3. By End User
    16.3. Brazil
        16.3.1. Pricing Analysis
        16.3.2. Market Share Analysis, 2022
            16.3.2.1. By Technology
            16.3.2.2. By Procedure
            16.3.2.3. By End User
    16.4. Mexico
        16.4.1. Pricing Analysis
        16.4.2. Market Share Analysis, 2022
            16.4.2.1. By Technology
            16.4.2.2. By Procedure
            16.4.2.3. By End User
    16.5. Germany
        16.5.1. Pricing Analysis
        16.5.2. Market Share Analysis, 2022
            16.5.2.1. By Technology
            16.5.2.2. By Procedure
            16.5.2.3. By End User
    16.6. UK
        16.6.1. Pricing Analysis
        16.6.2. Market Share Analysis, 2022
            16.6.2.1. By Technology
            16.6.2.2. By Procedure
            16.6.2.3. By End User
    16.7. France
        16.7.1. Pricing Analysis
        16.7.2. Market Share Analysis, 2022
            16.7.2.1. By Technology
            16.7.2.2. By Procedure
            16.7.2.3. By End User
    16.8. Spain
        16.8.1. Pricing Analysis
        16.8.2. Market Share Analysis, 2022
            16.8.2.1. By Technology
            16.8.2.2. By Procedure
            16.8.2.3. By End User
    16.9. Italy
        16.9.1. Pricing Analysis
        16.9.2. Market Share Analysis, 2022
            16.9.2.1. By Technology
            16.9.2.2. By Procedure
            16.9.2.3. By End User
    16.10. Poland
        16.10.1. Pricing Analysis
        16.10.2. Market Share Analysis, 2022
            16.10.2.1. By Technology
            16.10.2.2. By Procedure
            16.10.2.3. By End User
    16.11. Russia
        16.11.1. Pricing Analysis
        16.11.2. Market Share Analysis, 2022
            16.11.2.1. By Technology
            16.11.2.2. By Procedure
            16.11.2.3. By End User
    16.12. Czech Republic
        16.12.1. Pricing Analysis
        16.12.2. Market Share Analysis, 2022
            16.12.2.1. By Technology
            16.12.2.2. By Procedure
            16.12.2.3. By End User
    16.13. Romania
        16.13.1. Pricing Analysis
        16.13.2. Market Share Analysis, 2022
            16.13.2.1. By Technology
            16.13.2.2. By Procedure
            16.13.2.3. By End User
    16.14. India
        16.14.1. Pricing Analysis
        16.14.2. Market Share Analysis, 2022
            16.14.2.1. By Technology
            16.14.2.2. By Procedure
            16.14.2.3. By End User
    16.15. Bangladesh
        16.15.1. Pricing Analysis
        16.15.2. Market Share Analysis, 2022
            16.15.2.1. By Technology
            16.15.2.2. By Procedure
            16.15.2.3. By End User
    16.16. Australia
        16.16.1. Pricing Analysis
        16.16.2. Market Share Analysis, 2022
            16.16.2.1. By Technology
            16.16.2.2. By Procedure
            16.16.2.3. By End User
    16.17. New Zealand
        16.17.1. Pricing Analysis
        16.17.2. Market Share Analysis, 2022
            16.17.2.1. By Technology
            16.17.2.2. By Procedure
            16.17.2.3. By End User
    16.18. China
        16.18.1. Pricing Analysis
        16.18.2. Market Share Analysis, 2022
            16.18.2.1. By Technology
            16.18.2.2. By Procedure
            16.18.2.3. By End User
    16.19. Japan
        16.19.1. Pricing Analysis
        16.19.2. Market Share Analysis, 2022
            16.19.2.1. By Technology
            16.19.2.2. By Procedure
            16.19.2.3. By End User
    16.20. South Korea
        16.20.1. Pricing Analysis
        16.20.2. Market Share Analysis, 2022
            16.20.2.1. By Technology
            16.20.2.2. By Procedure
            16.20.2.3. By End User
    16.21. GCC Countries
        16.21.1. Pricing Analysis
        16.21.2. Market Share Analysis, 2022
            16.21.2.1. By Technology
            16.21.2.2. By Procedure
            16.21.2.3. By End User
    16.22. South Africa
        16.22.1. Pricing Analysis
        16.22.2. Market Share Analysis, 2022
            16.22.2.1. By Technology
            16.22.2.2. By Procedure
            16.22.2.3. By End User
    16.23. Israel
        16.23.1. Pricing Analysis
        16.23.2. Market Share Analysis, 2022
            16.23.2.1. By Technology
            16.23.2.2. By Procedure
            16.23.2.3. By End User
17. Market Structure Analysis
    17.1. Competition Dashboard
    17.2. Competition Benchmarking
    17.3. Market Share Analysis of Top Players
        17.3.1. By Regional
        17.3.2. By Technology
        17.3.3. By Procedure
        17.3.4. By End User
18. Competition Analysis
    18.1. Competition Deep Dive
        18.1.1. Medtronic
            18.1.1.1. Overview
            18.1.1.2. Product Portfolio
            18.1.1.3. Profitability by Market Segments
            18.1.1.4. Sales Footprint
            18.1.1.5. Strategy Overview
                18.1.1.5.1. Marketing Strategy
        18.1.2. TERUMO CORPORATION
            18.1.2.1. Overview
            18.1.2.2. Product Portfolio
            18.1.2.3. Profitability by Market Segments
            18.1.2.4. Sales Footprint
            18.1.2.5. Strategy Overview
                18.1.2.5.1. Marketing Strategy
        18.1.3. Guidant Group
            18.1.3.1. Overview
            18.1.3.2. Product Portfolio
            18.1.3.3. Profitability by Market Segments
            18.1.3.4. Sales Footprint
            18.1.3.5. Strategy Overview
                18.1.3.5.1. Marketing Strategy
        18.1.4. MAQUET Holding B.V. & Co. K.G
            18.1.4.1. Overview
            18.1.4.2. Product Portfolio
            18.1.4.3. Profitability by Market Segments
            18.1.4.4. Sales Footprint
            18.1.4.5. Strategy Overview
                18.1.4.5.1. Marketing Strategy
        18.1.5. Vitalitec International, Inc
            18.1.5.1. Overview
            18.1.5.2. Product Portfolio
            18.1.5.3. Profitability by Market Segments
            18.1.5.4. Sales Footprint
            18.1.5.5. Strategy Overview
                18.1.5.5.1. Marketing Strategy
        18.1.6. Novadaq Technologies Inc
            18.1.6.1. Overview
            18.1.6.2. Product Portfolio
            18.1.6.3. Profitability by Market Segments
            18.1.6.4. Sales Footprint
            18.1.6.5. Strategy Overview
                18.1.6.5.1. Marketing Strategy
        18.1.7. KARL STORZ GmbH & Co. K.G
            18.1.7.1. Overview
            18.1.7.2. Product Portfolio
            18.1.7.3. Profitability by Market Segments
            18.1.7.4. Sales Footprint
            18.1.7.5. Strategy Overview
                18.1.7.5.1. Marketing Strategy
        18.1.8. Edwards Lifesciences
            18.1.8.1. Overview
            18.1.8.2. Product Portfolio
            18.1.8.3. Profitability by Market Segments
            18.1.8.4. Sales Footprint
            18.1.8.5. Strategy Overview
                18.1.8.5.1. Marketing Strategy
        18.1.9. Genesee Biomedical Inc
            18.1.9.1. Overview
            18.1.9.2. Product Portfolio
            18.1.9.3. Profitability by Market Segments
            18.1.9.4. Sales Footprint
            18.1.9.5. Strategy Overview
                18.1.9.5.1. Marketing Strategy
        18.1.10. Sorin Group.
            18.1.10.1. Overview
            18.1.10.2. Product Portfolio
            18.1.10.3. Profitability by Market Segments
            18.1.10.4. Sales Footprint
            18.1.10.5. Strategy Overview
                18.1.10.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Recommendations

Healthcare

Aortic Stents Grafts Market

September 2023

REP-GB-865

215 pages

Healthcare

Thoracic Vascular Stent Grafts Market

July 2023

REP-GB-5926

322 pages

Healthcare

Hybrid Grafts Market

July 2022

REP-GB-15179

250 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Coronary Artery Bypass Graft Market

Schedule a Call